Skip to content

Global Health and Vaccination Research (GLOBVAC)

The primary objective of the GLOBVAC programme is to support high-quality research with potential for high impact that can contribute to sustainable improvements in health and health equity for poor people in low- and lower-middle income countries (LMIC).

Secondary objectives of the Programme are to: 

  • Develop and support internationally competitive and sustainable public and private research groups and institutions in Norway.
  • Develop and support national and international research collaboration and partnerships.
  • Secure capacity building through developing and supporting partnerships with research groups and institutions in low- and lower-middle-income countries.
  • Inform and increase awareness among policymakers, researchers and the public about needs for and results from global health research.

The Programme prioritizes projects in the following thematic areas:

1. Prevention and treatment of, and diagnostics for, communicable diseases with particular relevance for low and lower-middle income countries. This includes all aspects of epidemiology, diagnostics, discovery-/design of medicines and vaccines, development, evaluation/testing of medicines and vaccines, and delivery- /implementation of vaccination/treatment strategies. In particular, research that can lead from pre-clinical to clinical testing, participation in international product development with focus on diseases/pathogens with major global health burden are encouraged.

2. Family planning, reproductive, maternal, neonatal, child and youth health. All relevant health aspects are covered, including nutrition and child development as well as the follow-up of the recommendations of the UN Commission on Life-Saving Commodities for Women and Children (see report here PDF - 998 KB ).

3. Health systems and health policy research: that is production and application of knowledge to improve how societies organize themselves in order to achieve health goals. This includes research on financing, human resources, health services, health information systems and improved infrastructure for distribution and use of medical commodities; internationally, nationally and locally.

4. Implementation research: research on the promotion of uptake of research findings into public health programmes, and to expand knowledge on strategies for implementation and wider scaling-up of effective health interventions and health services. Research must be based upon and linked to health implementation activities in low-and lower-middle income countries. This includes implementation research applications that are thematically relevant for the other prioritized research areas in the call.

5. Innovation in technology and methods development for maternal and child health in settings where appropriate technologies are not available or non-existing. This includes developing products of high quality for prevention, diagnosis and treatment that are appropriate, accessible and affordable in resource-constrained settings.

Last updated: